Sign in
4/A

Changes in Ownership

Denali Therapeutics Inc. Filed Acc 0001209191-20-060790

Chief Medical Officer sold 17,500 shares at $18.07 ($316,157)

  • Chief Medical Officer acquired 12,235 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Ho Carole Chief Medical Officer 2018-11-15 Option exercise +12,235 $5.28 $64,601 195,625 I: show line 1 in the form
Ho Carole Chief Medical Officer 2018-11-15 Sale −17,500 $18.07 $316,157 178,125 I: show line 2 in the form
Open-market sales · 17,500 sh · avg $18.07 · $316,157

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Ho Carole Chief Medical Officer 2018-11-15 Option exercise · Stock Option (right to buy) −12,235 101,875 D: show line 3 in the form
Loading xslF345X03/doc4a.xml…